Gossamer Bio (GOSS) Stock Price, Quote, News & History

Comments

Gossamer Bio Inc (GOSS) Stock Price, Quote, News & History

GOSSNASDAQ

Trade with Public

$0.4560

0.01894.32%

At close: Mar 16, 5:00 PM EST

$0.4565

0.00050.11%

After Hours: 4:34 PM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$0.45

Close

$0.46

Volume / Avg.

6.11M / 14.02M

Day Range

$0.44 - $0.48

52 Wk Range

0.33 - 3.87

Market Cap

$105.66M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

23

Short Interest

15.95%

Days to Cover

1

Recent Gossamer Bio Inc News

PRO
HC Wainwright & Co. Maintains Buy on Gossamer Bio, Lowers Price Target to $5

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and lowers the price target from $10 to $5.

Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on Gossamer Bio, Lowers Price Target to $3

Oppenheimer analyst Andreas Argyrides maintains Gossamer Bio (NASDAQ:GOSS) with a Outperform and lowers the price target from $12 to $3.

Benzinga Newsdesk

These Analysts Slash Their Forecasts On Gossamer Bio

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-158.43M

Investing Cash Flow (TTM)

136.42M

Financing Cash Flow (TTM)

2.47M

Free Cash Flow (TTM)

-158.51M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-19.55M

Analyst Trends and Forecast

2

Jan

2

1

Feb

2

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$123.82M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.25

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-157.86%

Earnings Yield % (FWD)

-101.81%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.36

Company Debt

Total Debt

$198.26M

LT Debt

$198.26M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

$0

Total Cash

$8.93M

Debt to Equity

-

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

$0

Key Statistics

Open

$0.45

Close

$0.46

Volume / Avg.

6.11M / 14.02M

Day Range

$0.44 - $0.48

52 Wk Range

0.33 - 3.87

Market Cap

$105.66M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

23

Short Interest

15.95%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include S...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Gossamer Bio (GOSS) stock?

A

You can purchase shares of Gossamer Bio (NASDAQ:GOSS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Gossamer Bio (GOSS) competitors?

A

Other companies in Gossamer Bio’s space includes: Anixa Biosciences Inc (NASDAQ:ANIX), Fortress Biotech Inc (NASDAQ:FBIO), Gain Therapeutics Inc (NASDAQ:GANX), Korro Bio Inc (NASDAQ:KRRO) and Inovio Pharmaceuticals Inc (NASDAQ:INO).

Q

What is the forecast, or price target, for Gossamer Bio (GOSS) stock?

A

Gossamer Bio has a consensus price target of $5.90.

Q

What is the current price for Gossamer Bio (GOSS)?

A

The stock price for Gossamer Bio (NASDAQ: GOSS) is $0.4565 last updated March 16, 2026 at 4:34 PM EDT.

Q

Does Gossamer Bio (GOSS) pay a dividend?

A

There are no upcoming dividends for Gossamer Bio.

Q

When is Gossamer Bio (NASDAQ:GOSS) reporting earnings?

A

Gossamer Bio does not have any upcoming earnings scheduled.

Q

Is Gossamer Bio (GOSS) going to split?

A

There is no upcoming split for Gossamer Bio.

Q

What sector and industry does Gossamer Bio (GOSS) operate in?

A

Gossamer Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Anixa Biosciences Inc

Gain Therapeutics Inc

Inovio Pharmaceuticals Inc

NASDAQ:INO

$1.66

1.74%

MAIA Biotechnology Inc

Key Statistics

Open

$0.45

Close

$0.46

Volume / Avg.

6.11M / 14.02M

Day Range

$0.44 - $0.48

52 Wk Range

0.33 - 3.87

Market Cap

$105.66M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

23

Short Interest

15.95%

Days to Cover

1

Recent Gossamer Bio Inc News

PRO
HC Wainwright & Co. Maintains Buy on Gossamer Bio, Lowers Price Target to $5

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and lowers the price target from $10 to $5.

Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on Gossamer Bio, Lowers Price Target to $3

Oppenheimer analyst Andreas Argyrides maintains Gossamer Bio (NASDAQ:GOSS) with a Outperform and lowers the price target from $12 to $3.

Benzinga Newsdesk

These Analysts Slash Their Forecasts On Gossamer Bio

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-158.43M

Investing Cash Flow (TTM)

136.42M

Financing Cash Flow (TTM)

2.47M

Free Cash Flow (TTM)

-158.51M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-19.55M

Analyst Trends and Forecast

2

Jan

2

1

Feb

2

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$123.82M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.25

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-157.86%

Earnings Yield % (FWD)

-101.81%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.36

Company Debt

Total Debt

$198.26M

LT Debt

$198.26M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

$0

Total Cash

$8.93M

Debt to Equity

-

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

$0

Key Statistics

Open

$0.45

Close

$0.46

Volume / Avg.

6.11M / 14.02M

Day Range

$0.44 - $0.48

52 Wk Range

0.33 - 3.87

Market Cap

$105.66M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

23

Short Interest

15.95%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include S...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry